Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Paolo Ascierto and Diana Giannarelli.
Paolo Ascierto
Connection Strength
1.187
Diana Giannarelli
  1. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med. 2021 03 31; 19(1):132.
    View in: PubMed
    Score: 0.234
  2. PD-L1 expression with immune-infiltrate evaluation and outcome prediction in melanoma patients treated with ipilimumab. Oncoimmunology. 2018; 7(12):e1405206.
    View in: PubMed
    Score: 0.196
  3. Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab. J Immunother Cancer. 2018 07 16; 6(1):74.
    View in: PubMed
    Score: 0.194
  4. Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab. J Transl Med. 2017 12 04; 15(1):244.
    View in: PubMed
    Score: 0.186
  5. Correlation between previous treatment with BRAF inhibitors and clinical response to pembrolizumab in patients with advanced melanoma. Oncoimmunology. 2017; 6(3):e1283462.
    View in: PubMed
    Score: 0.175
  6. Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma. Cancer Immunol Immunother. 2014 Jul; 63(7):675-83.
    View in: PubMed
    Score: 0.144
  7. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. J Immunother Cancer. 2020 10; 8(2).
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.